Results 271 to 280 of about 178,297 (335)
Gastric cancer (GC) has high global incidence and mortality, with most cases diagnosed at advanced stages. Immunotherapy, particularly immune checkpoint blockers (ICBs), has shown promise, but not all patients benefit. This study applied consensus clustering based on anoikis‐related genes (ANRGs) to classify GC into two subclusters.
Xing Cai +5 more
wiley +1 more source
Analysis of clinicopathological and molecular characteristics of EBV-associated gastric cancer. [PDF]
Wu L +5 more
europepmc +1 more source
American Journal of Hematology, Volume 101, Issue 3, Page 628-632, March 2026.
Zhenbin Wei +19 more
wiley +1 more source
Crosstalk Between Intratumoral Microbes and Tumor Immunity: Implications for Tumor Therapy
ABSTRACT Background Emerging studies indicate that microbes are present in tumor cells and immune cells. Intratumoral microbiota (ITM) constitute an important component of the tumor immune microenvironment (TIME) and have an important impact on tumor progression and treatment. Objective Through the general elaboration of ITM represented by bacteria and
Fengxue Li +13 more
wiley +1 more source
Collaborative breakthroughs in precision diagnosis and treatment of nasopharyngeal cancer: Biomarker‑driven screening and endoscopic minimally invasive surgery reshape the new paradigm of early intervention (Review). [PDF]
Jin E, Lin W, Zeng X.
europepmc +1 more source
A 66‐year‐old man with acute retinal necrosis
Brain Pathology, Volume 36, Issue 2, March 2026.
Shino Magaki +3 more
wiley +1 more source
High intratumor heterogeneity in DLBCL is associated with reduced event‐free survival, particularly in the ABC subtype. Tumors with high clonal composition exhibit more aggressive biological behavior compared to monoclonal tumors in the ABC subtype of DLBCL.
Takahiro Haeno +8 more
wiley +1 more source

